AVBP
ArriVent BioPharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$23.90
-0.19 ▼ -0.81%
🌙 3월 13일 7:06 PM ET (한국 3/14 08:06)
$24.13
+0.23 ▲ +0.97%
| Index | RUT | P/E | - | EPS (ttm) | -4.46 | Insider Own | 34.6% | Shs Outstand | 0.04B | Perf Week | 2.01% |
| Market Cap | 1.06B | Forward P/E | - | EPS next Y | 13.08% | Insider Trans | -3.51% | Shs Float | 0.03B | Perf Month | 10.55% |
| Enterprise Value | 0.74B | PEG | - | EPS next Q | -0.89 | Inst Own | 71.24% | Short Float | 24.23% | Perf Quarter | -1.85% |
| Income | -0.17B | P/S | - | EPS this Y | 12.65% | Inst Trans | 3.56% | Short Ratio | 13.69 | Perf Half Y | 25.66% |
| Sales | 0.00B | P/B | 3.3 | EPS next 5Y | 29.7% | ROA | -54.7% | Short Interest | 7.00M | Perf YTD | 18.79% |
| Book/sh | 7.24 | P/C | 3.38 | EPS past 3/5Y | -57.73% -29.43% | ROE | -58.88% | 52W High | -12.2% ($27.22) | Perf Year | 9.89% |
| Cash/sh | 7.08 | P/FCF | - | Sales past 3/5Y | - | ROIC | -54.13% | 52W Low | 54.49% ($15.47) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -86.21% | Gross Margin | - | Volatility(W/M) | 7.54% 6.82% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.72 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 12.83 | EPS Q/Q | -36.79% | Profit Margin | - | RSI (14) | 51.77 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 12.83 | Sales Q/Q | - | SMA20 | 0.43% ($23.8) | Beta | 0.85 | Target Price | $42.25 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | 5.97% ($22.55) | Rel Volume | 0.52 | Prev Close | $24.09 |
| Employees | 77 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 0.79% - | SMA200 | 13.02% ($21.15) | Avg Volume(3M) | 0.51M | Price | $23.9 |
| IPO | 2024/1/26 | Option/Short | Yes/Yes | Trades | 3577 | Volume | 264,098 | Change | -0.81% |
뉴스 로딩 중...